Key Dates

Related Announcements

RFA-DA-23-011: Registry of Medical Cannabis Use and Health Outcomes (UM1 - Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

On June 14, 2022, NIDA issued the Funding Opportunity Announcement (FOA) RFA-DA-23-011: Registry of Medical Cannabis Use and Health Outcomes (UM1 - Clinical Trial Optional). To assist potential applicants to the above-referenced FOA, this Notice provides information regarding the availability of a Frequently Asked Questions (FAQ) document.

The FAQ is available on the NIDA Web site at NIDA Funding Opportunities | National Institute on Drug Abuse (NIDA) (nih.gov). All applicants are encouraged to review the FAQ prior to submitting their application. We anticipate updating the FAQ page as needed and recommend that applicants check back for updates to the FAQ regularly until their submission date.

Inquiries

Please direct all inquiries to:

Heather L. Kimmel, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: heather.kimmel@nih.gov